Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial
{{output}}
Aim: To evaluate the safety and tolerability of repeating 14-day treatment with zuranolone (30 mg) followed by a 6-week follow-up period (one treatment cycle) for a maximum of six treatment cycles in Japanese participants with ma... ...
